Title: 2015 ACVIM Forum Research Abstract Program Document date: 2015_5_27
ID: 3pnuj5ru_298
Snippet: A double blind, placebo-controlled, crossover design study was preformed. Eight diabetic cats with a body condition score (BCS) ≥ 4/9 without any evidence of significant concurrent disease based on routine screening tests were recruited. All cats had been treated with glargine insulin and maintained a stable body weight for a minimum of one month prior to enrolment. Glycemic parameters monitored included serum fructosamine, fasting and postpran.....
Document: A double blind, placebo-controlled, crossover design study was preformed. Eight diabetic cats with a body condition score (BCS) ≥ 4/9 without any evidence of significant concurrent disease based on routine screening tests were recruited. All cats had been treated with glargine insulin and maintained a stable body weight for a minimum of one month prior to enrolment. Glycemic parameters monitored included serum fructosamine, fasting and postprandial blood glucose concentrations, mean blood glucose concentration for a blood glucose curve (BCG), and the total daily dose (TDD) of insulin required. Fasting and postprandial blood samples were collected for measurement of insulin and glucagon and fasting blood samples for leptin and adiponectin on the day 0, 7, 28, 42 of both arms of the study. All assays used in this study had previously been validated for use in cats.
Search related documents:
Co phrase search for related documents- BCS body condition score and body condition score: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- BCS body condition score and body weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- BCS body condition score and condition score: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- blood glucose and body condition score: 1, 2, 3
- blood glucose and body weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- blood glucose and condition score: 1, 2, 3
- blood glucose and daily dose: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- blood glucose and design study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- blood glucose and glargine insulin: 1, 2, 3, 4, 5
- blood glucose concentration and body condition score: 1, 2
- blood glucose concentration and body weight: 1, 2, 3, 4
- blood glucose concentration and condition score: 1, 2
- blood glucose concentration and design study: 1, 2
- blood sample and body condition score: 1, 2, 3, 4
- blood sample and body weight: 1, 2, 3, 4, 5, 6, 7, 8
- blood sample and concurrent disease: 1
- blood sample and condition score: 1, 2, 3, 4
- blood sample and design study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- body condition score and condition score: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
Co phrase search for related documents, hyperlinks ordered by date